Eric Weisblum, CEO of Silo Pharma ($SILO), made seven open market purchases of common shares totaling about $12,000 over the last 365 days, with the most recent on December 15, 2025. His activity ranks 4161st out of 4983 insiders in the database by purchase amount, well below the average of $1.46 million across 3.29 transactions per insider. Weisblum reported no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 2500 | $0.42 | 216,932.0000 | 9,331,346 | 1.17% | 0.03% |
| Dec. 15, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 2500 | $0.41 | 214,432.0000 | 9,331,346 | 1.18% | 0.03% |
| Nov. 21, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 1000 | $0.37 | 211,932.0000 | 9,331,346 | 0.47% | 0.01% |
| Nov. 20, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 1000 | $0.37 | 210,932.0000 | 9,331,346 | 0.48% | 0.01% |
| Nov. 18, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 7500 | $0.40 | 205,432.0000 | 9,331,346 | 3.79% | 0.08% |
| Nov. 19, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 4500 | $0.41 | 209,932.0000 | 9,331,346 | 2.19% | 0.05% |
| May 27, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | P | Common Stock | 10000 | $0.43 | 197,932.0000 | 4,484,456 | 5.32% | 0.22% |
| May 23, 2025 | Silo Pharma, Inc. | $SILO | Weisblum Eric | Chief Executive Officer | A | Options (right to buy) | 200000 | $0.00 | 387,932.0000 | 4,484,456 | 106.42% | 4.46% |
| Dec. 13, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.84 | 187,932.0000 | 4,301,847 | 1.35% | 0.06% |
| Nov. 22, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.90 | 185,432.0000 | 4,301,847 | 1.37% | 0.06% |
| Nov. 20, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.95 | 182,932.0000 | 4,301,847 | 1.39% | 0.06% |
| June 11, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 562 | $1.08 | 175,994.0000 | 2,866,934 | 0.32% | 0.02% |
| June 12, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 4438 | $1.11 | 180,432.0000 | 2,866,934 | 2.52% | 0.15% |
| April 4, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 600 | $1.96 | 175,032.0000 | 2,866,934 | 0.34% | 0.02% |
| April 5, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 400 | $2.03 | 175,432.0000 | 2,866,934 | 0.23% | 0.01% |
| April 1, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 1100 | $1.91 | 174,432.0000 | 2,866,934 | 0.63% | 0.04% |
| March 28, 2024 | Silo Pharma, Inc. | $SILO | Weisblum Eric | CEO and President | P | Common Stock | 3408 | $1.94 | 173,332.0000 | 3,079,874 | 2.01% | 0.11% |